Old Well Partners, LLC Prothena Corp Public LTD CO Transaction History

Old Well Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$42.11 - $73.26 $203,138 - $353,406	-4,824 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$48.2 - $78.89 $149,420 - $244,559	-3,100 Reduced 39.12%	4,824 $344,000
Q2 2021 Aug 16, 2021	SELL	$21.63 - $57.65 $49,035 - $130,692	-2,267 Reduced 22.25%	7,924 $407,000
Q1 2021 May 17, 2021	BUY	$11.0 - $28.24 $112,101 - $287,793	10,191 New	10,191 $256,000

187

45.4M

119K

144K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $957M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Old Well Partners, LLC with notifications on news.